While most people who contracted the COVID-19 virus are back to enjoying their normal activities surrounded by others, that’s not the case for those who have undergone cancer or leukemia treatments and have weakened immune systems.
Yale Cancer Center researcher Jeffrey Townsend decided to make that dilemma his recent focus. He extrapolated data from many studies already done on COVID-19.
Townsend said the Centers for Disease Control Preventions’ guidelines for immunocompromised patients is to get boosters “as needed.” Wanting to know more, Townsend set out with another researcher to give patients some guidance based on science.
- August 25, 2023Source: CBC
Experts agree vulnerable populations should get the latest COVID-19 booster shots, perhaps even more frequently than the broader public.
- August 21, 2023
New research led by scientists at Yale University and the University of North Carolina at Charlotte finds that the rate at which additional COVID-19 boosters are needed for cancer patients depends on the treatment they are receiving.
- June 08, 2023
Research studies focused on cancer, climate change, COVID-19, and Medicaid spending took top honors this year at the Yale School of Public Health.
- April 27, 2023Source: Smithsonian Magazine
Even as Covid-19 recedes from its position as America’s third-leading cause of death in 2022, it remains on track to be a top-ten cause of death this year with the emergence of new variants, such as XBB.1.5 (representing 84 percent of U.S. cases as of April 1). Given the latest federal guidelines on boosters, the public understandably seeks clarity about what this all means for them. Here’s what you need to know about getting your next vaccine.
- January 19, 2023Source: USA Today
Healthy people should get annual COVID-19 boosters to prevent widespread outbreaks, suggests a new study from Yale University and the University of North Carolina at Charlotte.
- January 10, 2023
A team of scientists led by faculty at the Yale School of Public Health and the University of North Carolina at Charlotte finds that updated boosters administered on an annual or biannual basis greatly reduce the long-term risk of infection from endemic COVID-19.
- January 04, 2023
A new open-source software package called cancereffectsizeR developed by the Townsend Lab greatly improves the ability of data scientists and clinical analysts to pinpoint specific genetic mutations that drive cancer.
- January 03, 2023
There’s a new tool available to help researchers choose the most appropriate scientific journal for the potential publication of their manuscript. Say hello to Jot: a free, open-source web application that matches manuscripts in the fields of biomedicine and life sciences with suitable journals, based on a manuscript's title, abstract, and (optionally) citations.
- November 15, 2022
Yale medical students get hands-on exposure to the field of urology and learn why it's considered a multidisciplinary specialty.